Despite a slowing economy, drug stocks such as Abbott Labs (ABT) and Genentech (DNA) posted positive earnings reports.

Now investors are turning attention to Pfizer (PFE), Amgen (AMGN), Merck (MRK) and other pharma firms hoping they too report healthy results.

Is health care the best defensive play in this market? Find out in this Web Extra! Watch the video now.

This content is only available online - you won't find these trades on TV.